PATRICIA: A phase II study of palbociclib and trastuzumab with or without letrozole in previously treated, postmenopausal patients with HER2-positive metastatic breast cancer.

被引：1
|
作者：
Villagrasa, Patricia
Gonzalez, Xavier
Oliveira, Mafalda
Vazquez, Josep
De La Pena, Lorena
Llobet-Canela, Marta
Prat, Aleix
Ciruelos, Eva
机构：
[1] SOLTI Breast Canc Res Grp, Barcelona, Spain
[2] Quiron Dexeus Univ Hosp, Translat Res Unit, Dr Rosell Oncol Inst, Barcelona, Spain
[3] Vall dHebron Univ Hosp VHIO, Barcelona, Spain
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.tps642
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS642
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients:: a clinical study
    Carabantes-Ocon, F.
    Saez-Lara, E.
    Burgos-Garcia, L.
    Villar-Chamorro, E.
    Casaus-Hazanas, A.
    Luna, S.
    Martinez, C.
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [32] Phase II Study of S-1 in Combination with Trastuzumab for HER2-positive Metastatic Breast Cancer
    Takashima, Tsutomu
    Nakayama, Takahiro
    Yoshidome, Katsuhide
    Kawajiri, Hidemi
    Kamigaki, Shunji
    Tsurutani, Junji
    Arai, Takashi
    Ito, Toshikazu
    Komoike, Yoshihumi
    Doi, Takako
    Masuda, Norikazu
    Miyauchi, Keisuke
    Miyoshi, Yasuo
    Sakamoto, Junichi
    Morita, Satoshi
    Taguchi, Tetsuya
    ANTICANCER RESEARCH, 2014, 34 (07) : 3583 - 3588
  • [33] A phase II study of pembrolizumab, letrozole and palbociclib in patients with metastatic estrogen receptor positive breast cancer
    Yuan, Yuan
    Yost, Susan E.
    Lee, Jin Sun
    Egelston, Colt
    Frankel, Paul H.
    Ruel, Christopher
    Padam, Simran
    Tang, Aileen
    Martinez, Norma
    Portnow, Jana
    Yeon, Christina
    Presant, Cary
    Rajurkar, Swapnil
    Sedrak, Mina
    Patel, Niki
    Lee, Peter
    Mortimer, Joanne
    CANCER RESEARCH, 2020, 80 (04)
  • [34] A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
    Gavila, J.
    De La Haba, J.
    Bermejo, B.
    Rodriguez-Lescure, A.
    Anton, A.
    Ciruelos, E.
    Brunet, J.
    Munoz-Couselo, E.
    Santisteban, M.
    Rodriguez Sanchez, C. A.
    Santaballa, A.
    Sanchez Rovira, P.
    Garcia Saenz, J. a.
    Ruiz-Borrego, M.
    Guerrero-Zotano, A. L.
    Huerta, M.
    Cotes-Sanchis, A.
    Lao Romera, J.
    Aguirre, E.
    Cortes, J.
    Llombart-Cussac, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (03): : 420 - 428
  • [35] A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
    J. Gavilá
    J. De La Haba
    B. Bermejo
    Á. Rodríguez-Lescure
    A. Antón
    E. Ciruelos
    J. Brunet
    E. Muñoz-Couselo
    M. Santisteban
    C. A. Rodríguez Sánchez
    A. Santaballa
    P. Sánchez Rovira
    J. Á. García Sáenz
    M. Ruiz-Borrego
    A. L. Guerrero-Zotano
    M. Huerta
    A. Cotes-Sanchís
    J. Lao Romera
    E. Aguirre
    J. Cortés
    A. Llombart-Cussac
    Clinical and Translational Oncology, 2020, 22 : 420 - 428
  • [36] Phase II randomized trial of neoadjuvant trastuzumab and pertuzumab with either palbociclib plus letrozole or paclitaxel for postmenopausal women with estrogen receptor-positive/HER2-positive breast cancer - The TOUCH trial
    Biganzoli, Laura
    Brain, Etienne
    Malorni, Luca
    Gombos, Andrea
    Hasler-Strub, Ursula
    Zamagni, Claudio
    Chakiba, Camille
    Roschitzki-Voser, Heidi
    Regan, Meredith M.
    CANCER RESEARCH, 2021, 81 (04)
  • [37] Trastuzumab emtansine in HER2-positive metastatic breast cancer
    Montemurro, Filippo
    LANCET ONCOLOGY, 2017, 18 (06): : 696 - 697
  • [38] Trastuzumab therapy in HER2-positive, metastatic breast cancer
    Smith, A. D.
    Guilbert, K.
    Lister, D.
    Streilein, S.
    Bourrier, V. C.
    Lozar, B.
    Navaratnam, S.
    Harding, G. A.
    Pitz, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Trastuzumab Deruxtecan in HER2-positive metastatic Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (08) : 670 - 670
  • [40] Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
    Shitara, Kohei
    Bang, Yung-Jue
    Iwasa, Satoru
    Sugimoto, Naotoshi
    Ryu, Min-Hee
    Sakai, Daisuke
    Chung, Hyun-Cheol
    Kawakami, Hisato
    Yabusaki, Hiroshi
    Lee, Jeeyun
    Saito, Kaku
    Kawaguchi, Yoshinori
    Kamio, Takahiro
    Kojima, Akihito
    Sugihara, Masahiro
    Yamaguchi, Kensei
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25): : 2419 - 2430
12345